About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, November 6th, 2013

The QualityStocks
Daily Stock List


Global Resource Energy, Inc. (GBEN)

Pumps and Dumps reported recently on Global Resource Energy, Inc. (GBEN), SmallCapInvestorDaily, PennyStockScholar, OTCtipReporter, did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Global Resource Energy, Inc. is a development stage clean technology company headquartered in Las Vegas, Nevada. The Company is working to deliver clean renewable energy globally, with an initial focus on North America. The Company's principal focus is to acquire evolving renewable technologies and to deliver reliable, clean energy, which undergoes harvesting from local sustainable natural resources. The Company will provide services and solutions to businesses, communities, and individuals. Global Resource Energy’s shares trade on the OTC Markets’ OTCQB.

The Company recently entered into an agreement with a license holder of a major technology that shows significant promise under laboratory conditions. The MyCroft® fuel cell is a 'recirculating loop electric generator' (R-LEG). It utilizes the motion of hydrogen within a sealed loop to create electricity that appears scalable to an extensive number of commercial applications. The system is practical and effective. It could undergo development for small-scale (micro power) medical applications. Economies of scale could ultimately lead to industrial and residential applications. 

The system has undergone investigation with measured performance documented by researchers from a highly respected research and testing laboratory. Further research and development is underway. Global Resource Energy plans to optimize the management and development of the MyCroft® technology by way of several funding scenarios.

Global Resource Energy’s intention is to engage in the licensing and reselling or distribution of clean technologies. At present, the Company has one distribution contract for the distribution of light-emitting diode (LED) lights. The Company has made an advance to acquire Certified Emission Reduction credits (CER's) for future resale. The Company has not yet began operations and has not yet received the CER's for redistribution.

In January 2013, Global Resource Energy announced the pre-purchase of these 66,000 Certified Emission Reduction Credits (CER’s) from BluForest, Inc. The total purchase price of $660,000.00 is to be paid to BluForest in the form of 3,000,000 restricted shares of Global Resource Energy. BluForest is a publicly traded carbon offsets marketing company. Certified Emission Reductions (CERs) are a type of emissions unit (or carbon credits).

Global Resource Energy, Inc. (GBEN), closed Wednesday's trading session at $0.0055, up 61.76%, on 3,874,934 volume with 82 trades. The average volume for the last 60 days is 93,050 and the stock's 52-week low/high is $0.003/$0.26.

Advanced Cell Technology, Inc. (ACTC)

Ceocast News reported last week on Advanced Cell Technology, Inc. (ACTC), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Based in Santa Monica, California, Advanced Cell Technology, Inc. is a leader in the field of regenerative medicine. The Company is a biotechnology enterprise applying cellular technology in this field. They apply stem cell-based technologies for adult and "embryo-safe" human embryonic stem cells, and other proprietary methods in the field of regenerative medicine.

The Company has three cellular product platforms based on ground-breaking stem cell technology. They developed, and hold in their repertoire, the first-ever proven alternative method for successful hESC generation without harm to the embryo on which they hold broad Intellectual Property (IP) protection. This is called the "single-cell blastomere" technique.

Advanced Cell Technology is concentrating on commercializing their human embryonic stem cell (hESC)-based Retinal Pigment Epithelial (RPE) therapy for degenerative retinal disease. The Company earlier initiated two Phase 1/2 clinical trials. Moreover, they are developing their human embryonic stem cell (hESC)-based Hemangioblast (HG) platform for the treatment of blood and cardiovascular diseases. The development of this program is in collaboration with CHA Biotech of Korea.

Advanced Cell Technology is also developing a method for scaled manufacturing of Mesenchymal Stem Cells (MSCs) from renewable pluripotent stem cell sources. Furthermore, they are developing therapeutic platforms using Corneal Endothelial Cells for use in treating corneal blindness, and retinal neural progenitor cells for use in treating glaucoma.

This past September, Advanced Cell Technology announced that they filed an Investigational New Animal Drug (INAD) application with the Food and Drug Administration (FDA) to test the Company’s proprietary “off-the-shelf” mesenchymal stem cells (MSC) in a spectrum of different disease indications. The studies will evaluate the safety and efficacy of the Company’s pluripotent stem cell-derived MSCs in ten spontaneous disease models in dogs that are similar to different human inflammatory and immune-mediated diseases. The INAD is directed to ten canine disorders corresponding to hepatitis, glomerulonephritis, osteoarthritis, Crohn’s disease, inflammatory bowel disease, spinal cord/disc disease, meningoencephalitis, hemolytic anemia, pancreatitis, and sepsis.

Advanced Cell Technology, Inc. (ACTC), closed Wednesday's trading session at $0.0642, up 1.42%, on 4,142,995 volume with 150 trades. The average volume for the last 60 days is 3,418,960 and the stock's 52-week low/high is $0.052/$0.0981.

Bergio International, Inc. (BRGO)

PennyStocks24, Pinnacle Stock Alerts, Momentum Hunter, PennyAuthority.com, Penny King, ElitePennyStocks, Paradise Penny Stocks, Eastwind Research, Penny Lane Reports, VipStockReports, Stock Analyzer, ExclusiveStocks, AwesomePennyPicks, Stock Brain, Liquid Pennies, fusionspicks, and AwesomeStocks reported earlier on Bergio International, Inc. (BRGO), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed Bergio International, Inc. is a leading jeweler headquartered in Fairfield, New Jersey. The Company is creating one of the world's largest diversified jewelry designers and manufacturers by way of acquisitions and consolidation. Bergio sells their jewelry to distributors, retailers, and other wholesalers throughout the United States. The Company has manufacturing control over their line because of their manufacturing facility in New Jersey and subcontracts with other facilities in the U.S. and Italy.

At present, Bergio International sells their jewelry to approximately 50 jewelry retailers across the nation. The Company offers an array of products created from precious metals. These include gold, platinum, Karat gold, diamonds, and other precious stones. Bergio offers a collection of charms, crosses, and other add-on pieces. Additionally, the Company offers fashion jewelry, including necklaces, pendants, earrings, bracelets and rings. Furthermore, Bergio offers a couture line, and a bridal line that comprises wedding sets, engagement rings, and wedding bands for men and women.

Under the Bergio umbrella there are three separate collections: Bergio Fine, Bergio Bridal, and Bergio Couture. Bergio Fine consists of 18kt gold and sterling silver with diamond collections. Bergio Bridal is a contemporary collection of engagement rings, eternity bands and bridal sets in platinum and 18kt gold. Bergio Couture consists of limited edition offerings.

Yesterday, Bergio International announced a number of new updates involving ShopHQ, success at the Yerevan jewelry show, further increased web presence via social media, and the use of convertible funding. Bergio was once again featured on ShopHQ with a successful airing on October 23, 2013. In addition, Bergio recently exhibited at the annual Yerevan jewelry show. At the show much of the Bergio line was very well received by Armenian and Russian retailers and consumers.

Concerning social media, the Bergio Facebook page increased from 10,500 likes to 23,000 likes. There have been further increases in followers on Twitter, Instagram and Pinterest. Moreover, the Bergio website (www.bergio.com) again increased its web ranking by approximately another 2 million points.

Bergio International, Inc. (BRGO), closed Wednesday's trading session at $0.0007, up 16.67%, on 176,088,329 volume with 230 trades. The average volume for the last 60 days is 47,142,614 and the stock's 52-week low/high is $0.0002/$0.005.

Terra Tech Corp. (TRTC)

SmallCapVoice, Jet-Life Penny Stocks, and PennyStocks24 reported earlier on Terra Tech Corp. (TRTC), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Terra Tech Corp., by way of their wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. Terra Tech integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. The Company works closely with expert horticulturists, engineers, and plant scientists to develop and manufacture advanced proprietary products for the developing urban agricultural industry and individual hobbyists. Terra Tech is based in Irvine, California.

Terra Tech operates in two diverse markets. One is Commercial Agriculture; the other is Retail Agriculture. Pertaining to Commercial, Terra Tech works with customers to help design, develop, and manufacture cultivation systems that maximize their space and decrease their energy costs. Terra Tech offers rooftop/vertical hydroponic and aeroponic systems to custom designed greenhouse management systems.
Regarding Retail, Terra Tech, through GrowOp Technology, designs and manufactures an advanced and affordable line of horticulture equipment. GrowOp Technology operates out of their warehouse facility in Oakland, California. Terra Tech also focuses on medical cannabis cultivation technology.

In addition, Terra Tech, via their wholly-owned subsidiary Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce. This produce sells through leading grocery stores including Shoprite, Food Emporium and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, and Pennsylvania. In early October, Terra Tech announced that their line of sustainable and locally grown produce is now available at BJ's Wholesale Club, Inc., a leading operator of membership warehouse clubs in the Eastern United States.

In addition, in October, Terra Tech released a corporate update and revenue guidance of $2,000,000 for the full year 2013. Sales through the Company’s Edible Garden and their line of locally grown hydroponic produce, distributed throughout the Northeast, have been strong for Terra Tech since the close of the merger in April 2013. Company Management expects to realize approximately $2 million in revenue for the full year 2013.

Terra Tech Corp. (TRTC), closed Wednesday's trading session at $0.064, up 4.92%, on 1,393,608 volume with 97 trades. The average volume for the last 60 days is 1,313,304 and the stock's 52-week low/high is $0.0575/$0.195.

Solitron Devices, Inc. (SODI)

Stock Profile reported previously on Solitron Devices, Inc. (SODI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Solitron Devices, Inc. designs, develops, manufactures, and markets solid-state semiconductor components and related devices mainly for the military and aerospace markets. The Company sells their products directly, and through a network of manufacturers’ representatives and distributors. A vertically integrated hybrid manufacturer, Solitron Devices incorporated in 1959; the Company has their corporate headquarters in West Palm Beach, Florida.

Solitron’s facility in Florida is approximately 47,000 square feet. This includes a 5,000 square feet class 10,000 clean room (FED-STD-209), and a 25,000 square feet class 100,000 clean room (FED-STD-209). In addition, 39 laminar flow hoods provide 100 class work areas. Solitron Device’s advanced semiconductor device and packaging technology has contributed to the success of almost every U.S. and European aerospace and defense program.
Solitron Devices manufactures a large selection of bipolar and metal oxide semiconductor (MOS) power transistors, power and control hybrids, junction and power MOS field effect transistors, and other related products. The majority of the Company's products are custom made pursuant to contracts with customers whose end products sell to the United States government. Other products, including Joint Army/Navy transistors, diodes, and Standard Military Drawings voltage regulators sell as standard or catalog items.

The Company’s semiconductor products are used as components of military, commercial, and aerospace electronic equipment, including ground and airborne radar systems, power distribution systems, missiles, missile control systems, and space crafts, and for non-military, scientific, as well as industrial applications. Solitron Devices has partnered since 1965 with major defense contractors to provide vital components to all major military, aerospace, and space programs. Solitron components have been used in more than 200 programs.

The Company provides support to all analog and mixed signal designs, whether they are power or small signal hybrids. Solitron considers, on a case-by-case basis, the support of digital and high frequency modules. The Company supports small, medium, as well as large volume requirements.

Solitron Devices, Inc. (SODI), closed Wednesday's trading session at $4.34, up 6.16%, on 111,478 volume with 50 trades. The average volume for the last 60 days is 2,865 and the stock's 52-week low/high is $3.20/$4.10.

Q Lotus Holdings, Inc. (QLTS)

PennyStocks24 and Information Solutions Group reported earlier on Q Lotus Holdings, Inc. (QLTS), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Chicago, Illinois-based Q Lotus Holdings, Inc. is a diversified financial services holding company whose shares trade on the OTCQB. The Company provides financing and acquires growing companies in which they believe their management participation in operations can create added value. Q Lotus’ primary investment focus is on providing equity and debt capital to growing and middle-market companies with increasing cash flow and rising income in the finance, real estate, and mining areas.

Q Lotus had two wholly owned subsidiaries as of June 30, 2013: QLI, whose operations through this date have consisted of the acquisition of certain mining claims, and MBC, which established to acquire the assets of MBC, LLC an asset based lending company that provides secured financing. Currently, Q Lotus Holdings’ business has consisted solely of holding mineral rights in a portfolio of minerals. The Company’s activities have been limited to the formation of the legal and business structure, business planning, the pursuit of capital and the exploration of possible acquisitions and investments.

The Company’s anticipation is that their chief revenue sources will come from revenues from acquired operations, and interest, dividends, rents, royalties and capital gains (from loans and equity investments) in start-up companies with proprietary technology and medium sized businesses with an established operating history. Q Lotus is continuing their work towards the development of their natural resource and mining business. Moreover, the Company is pursuing the realization of their present mining interests and looking for new investment opportunities. Q Lotus Holdings is also keeping their commitment to their interests in finance and real estate.

The Company has interests in 26 mining claims situated in Arizona, Utah, and Oregon. These claims include mineral rights for gold, silver, platinum, silica, and other diversified mineral assets. Q Lotus announced in June 2013 that they completed an internal study of the silica mining claims in Oregon, in which they have interests. They indicated that the results are encouraging, and that they are working with their relationships in Hong Kong and China to attain further input in connection with realizing on their opportunities with the silica mining claim interests.

Last week, Q Lotus Holdings management announced that they completed their evaluation and prioritization and are in the process of negotiating funding to monetize their mining claims and initiating mining operations through an expanded global network of qualified expert parties.

They completed the negotiation of an extension of their silica mining rights in Oregon that runs through January 31, 2014. At that time, the Company’s intention is to tender $5 million to the prior owners to secure permanent rights to those claims; they will go ahead with mining their silica in accordance with a profit-sharing arrangement with the prior owners. Additionally, Q Lotus plans to solidify their gold-mining rights in Arizona via an anticipated joint venture with Leanne Brier, the owners of the gold mining claims. 

Q Lotus Holdings, Inc. (QLTS), closed Wednesday's trading session at $0.0041, up 41.38%, on 6,797,272 volume with 69 trades. The average volume for the last 60 days is 3,224,366 and the stock's 52-week low/high is $0.0015/$0.12.

Petrosonic Energy, Inc. (PSON)

Wyatt Investment Research, Oakshire News Bulletin, Greenbackers, StockBlogs, and Pumps and Dumps reported earlier on Petrosonic Energy, Inc. (PSON), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed Petrosonic Energy, Inc. involves in heavy oil upgrading and related technologies. Currently, the Company’s principal focus is to provide technologies that upgrade heavy oil economically and in an environmentally friendly manner. Petrosonic has acquired 100 percent of the Intellectual Property (IP) for the Sonoprocess™ Technology, and an established processing plant. Their patented Sonoprocess™ utilizes cleantech sonic energy to de-asphalt heavy oil at much smaller scale and lower capital costs than conventional upgraders. It does so without the use of water or the release of emissions in the atmosphere.

Petrosonic's core sonic de-asphalting technology is a proprietary industrial scale sonic reactor. It transfers sonic energy on an industrial scale to physical, chemical, or biological processes. Their first Heavy Oil Processing facility will deliver cash flow and commercialization of the Sonoprocess™ on a continuous basis. Petrosonic is commercializing their patented Sonoprocess Heavy Oil Upgrading Technology via their wholly owned subsidiaries and joint ventures with third parties.

The Company is in an advanced stage of development as pertains to applications for heavy oil sands separation from oil sands and ecology pits, as well as oil separations from dill cuttings. Petrosonic Energy's commercial process improves heavy oil densities by 6 to 15 API from as low as 8 API. It reduces viscosities of oil by 99 percent to pipeline specifications and reduces sulphur and heavy metals by more than 50 percent.

In July 2013, Petrosonic Energy announced the execution of a new Memorandum Of Understanding (MOU) Agreement with East West Partners, LLC for the Company’s Sonoprocess™ and related technologies. Under the agreement, subject to completion of due diligence by both sides, the parties commit to sign a definitive Sales, Distribution, and License Agreement for the territories of China, Kazakhstan, and the State of California. The Sales, Distribution, and License Agreement will be on a non-exclusive basis. East West Partners is a U.S. energy company.

Recently, Petrosonic Energy provided a corporate update. The engineering firm, Gas Liquids Engineering of Calgary, Alberta completed third-party sonification tests in the Richmond, British Columbia facility. The results have been sent to a third party lab, Maxxam, in Calgary for separation and solvent recovery lab simulation. The results will be used to finalize the engineering and estimates of the asphaltene separation and solvent recovery equipment.

Additionally, Petrosonic reported that their emulsion testing process in Albania is continuing successfully and that along with the successful first test and sale reported on June 10, 2013, the Company is continuing to emulsify and provide product to their client.

Petrosonic Energy, Inc. (PSON), closed Wednesday's trading session at $0.31, up 1.64%, on 270,594 volume with 70 trades. The average volume for the last 60 days is 221,103 and the stock's 52-week low/high is $0.225/$1.46.

Alliqua, Inc. (ALQA)

Financial News Media and Paradise Penny Stocks reported earlier on Alliqua, Inc. (ALQA), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Alliqua, Inc. is a biopharmaceutical company with corporate headquarters in Langhorne, Pennsylvania. An advanced wound management and drug delivery enterprise, Alliqua, through their subsidiaries, concentrates on the development and manufacture of proprietary technologies in the fields of drug delivery and advanced wound care. The Company leverages their proprietary hydrogel technology platform to add value to their products and also those of their partners. Alliqua lists on the OTCQB.

Alliqua’s technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers capable of many chemical configurations. Hydrogel technology can be used to deliver therapeutic compounds by way of the skin. Hydrogels are gel-like or colloidal substances made of water and solids. Their hydrogels can be customized for diverse transdermal applications to address market opportunities in the treatment of wounds and the delivery of several drugs or other agents for pharmaceutical and cosmetic industries.

The Company’s drug delivery platform, in combination with certain active pharmaceutical ingredients, can also provide pharmaceutical companies with a transdermal technology to improve patient compliance and potentially extend the patent life of valuable drug franchises. Additionally, Alliqua’s contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua develops and manufactures electron-beam cross-linked sheet gels for customers. These clients include manufacturers of medical devices, cosmeceuticals, and other commercial product applications.

Alliqua presently markets their new line of 510(k) FDA-approved hydrogel products for wound care under the SilverSeal® brand and the sorbion sachet S and sorbion sana wound care products. SilverSeal® is a flexible, sterile, non-adherent hydrogel dressing that incorporates the antimicrobial properties of metallic silver coated fiber. SilverSeal® Hydrogel dressings are cross-linked polymer based gels that may be made into sheets.

In addition, Alliqua has their Hydress® product. Hydress® is a flexible, sterile, non-adherent hydrogel dressing that can absorb two-times its weight in exudate. Hydress® sheets can hold themselves in place. They are non-adherent and can be removed without causing additional trauma to the wound bed. 

Recently, Alliqua announced that they signed a distribution agreement with McKesson Medical-Surgical; McKesson’s U.S. distribution network will stock and offer for sale Alliqua's SilverSeal® and Hydress® wound dressings to healthcare customers across the country. McKesson Medical-Surgical will distribute SilverSeal® and Hydress® dressings to alternate site markets in all 50 U.S. States.

Alliqua, Inc. (ALQA), closed Wednesday's trading session at $0.087, up 6.10%, on 5,059,797 volume with 129 trades. The average volume for the last 60 days is 515,928 and the stock's 52-week low/high is $0.035/$0.104.


The QualityStocks
Company Corner


International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.147, off by 4.55%, on 372,116 volume with 71 trades. The stock’s average daily volume over the past 60 days is 663,609, and its 52-week low/high is $0.13/$0.41.

International Stem Cell Corp. announced today that it will host a conference call on Wednesday, November 13, 2013 to discuss its financial results for the three and nine months ended September 30, 2013. Dr. Simon Craw, Executive Vice President and Mr. Jay Novak, Chief Financial Officer of International Stem Cell will host the conference call and interested parties can attend via 1-877-941-1428 (U.S.) or 1-480-629-9665 (International) using Conference ID: 4648561. A webcast will also be available HERE.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation to Host Third Quarter 2013 Financial Results Conference Call at 11:00 a.m. ET on Wednesday, November 13, 2013

International Stem Cell Corporation Announces New Data From Parkinson's Disease Program

International Stem Cell Corporation to Present at 12th Annual BIO Investor Forum October 8-9th, 2013

Big Tree Group, Inc. (BIGG)

The QualityStocks Daily Newsletter would like to spotlight Big Tree Group, Inc. (BIGG). Today, Big Tree Group, Inc. closed trading at $0.23, up 4.55%, on 56,032 volume with 27 trades. The stock’s average daily volume over the past 60 days is 30,827, and its 52-week low/high is $0.055/$2.99.

Big Tree Group, Inc. (BIGG) is an authorized sales agent for thousands of toy manufacturers in China and provides multiple procurement services for international toy distributors and wholesalers. The company is headquartered in Shantou City of Guangdong province, a city known as the toy capital of the world. It’s here that Big Tree operates a 21,000-square-foot-showroom to display its products to thousands of international toy purchasers. The company has an on-site testing laboratory where all toys undergo rigorous testing to ensure both quality and function before reaching the showroom floor.

Big Tree Group serves as a “one-stop-shop” for the international sourcing and distribution of toys and other related products. Big Tree Group currently represents more than 8,000 toy manufacturers offering more than 300,000 varieties of toy products such as remote control toys, digital toys, sports toys, play sets, educational toys, dolls and infant toys. Big Tree conducts operations through both of their subsidiaries, Big Tree Brunei and Big Tree Shantou.

The company has developed and patented a proprietary construction toy, the Magic Puzzle (3D). The Big Tree Magic Puzzle has been well received but is currently promoted and distributed in only the Chinese domestic market. Global marketing and distribution of the Magic Puzzle is under evaluation and could create significant channels sales.

China is the world’s leading toy manufacturer and exporter, producing and distributing two-thirds of the multi-billion dollar toy industry’s global demand. The nation’s manufacturing is highly regional, with 70 percent of toy sales in China generated in the Guangdong province. Strategically located in this province, Big Tree has cultivated an extensive customer base in Asia and Europe and is strategically planning global expansion and distribution, especially in the Americas.

Big Tree’s operations are spearheaded by long-time China toy industry veteran CEO Wei Lin, who founded the toy export and import company Shantou Dashu Toy Corp. Ltd. He is supported by an seasoned and experienced management team proficient in operations management, marketing, sales, team management, education and accounting. Big Tree’s management team has established an aggressive growth strategy to expand sales and global product distribution by utilizing their expansive multi-lingual sales team to leverage industry contacts, identify strategic mergers and acquisitions, and maximize trade and industry opportunities. Disclaimer

Big Tree Group, Inc. Company Blog

Big Tree Group, Inc. News:

Big Tree Group Receives Purchase Orders Valued at $3.6 Million from a Leading Discount Retailer in Europe

Big Tree Group Passes Key International Inspections for Toy Business Practices Systems Quality Control and Safety

Big Tree Group Completes Delivery of Purchase Orders for U.S. Based Leading Operator of Dollar Stores Valued at Approximately $650,000

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.10, up 66.67%, on 1,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 33,252, and its 52-week low/high is $0.03/$0.15.

Global Payout, Inc. (GOHE) specializes in customized payment solutions for businesses and organizations worldwide. The company’s global network of banks and processing partners enable companies and organizations to efficiently deploy a customized payment solution configured specifically for each client. From solving a single payment issue to meeting an entire global payment requirement, Global Payout in conjunction with its partners delivers modular payment solutions.

Global Payout has a product line of prepaid "off the shelf" products that can be utilized or Global Payout can customize payment solutions for qualified businesses. By coupling its network of international banks and third-party processing relationships with an innovative payment platform, Global Payout enables organizations to "plug into" an efficient and cost effective method of paying employees, contractors, investors, and commissioned agents wherever they might be located in the world.

Global Payout began operations as a business to business provider of pre-paid debit cards for payroll and general spend programs. The company then launched a Prepaid Discover® card to meet the demand of its business clients in the United States. As a result of these efforts and with the input of their client base, Global Payout then greatly extended its reach by developing a new proprietary “payment platform” which enables companies and organizations to make necessary payments in every country a company does business. Clients can now make international payments without the need to establish banking relationships in each and every country they do business. Businesses now have an efficient, compliant and simplified system to make their all necessary international payments using Global Payout’s proprietary payment platform.

Global Payout delivers dependable and secure global payment solutions for companies worldwide. This relieves clients of burdensome and time consuming efforts to establish banking relationships everywhere they do business. The company’s “consolidated payment gateway” product can be configured specifically to the needs of each client within a short period of time. Global Payout is led by a management team comprised of pioneers in domestic and international payment delivery solutions. The company is well positioned to leverage their long standing international financial relationships to expand their services and global reach. Even during this expansion, Global Payout remains committed to serving domestic and international clients and providing them with customized one-stop solutions that address each client’s specific payment needs. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

ImageWare Systems Provides Next Generation Cloud Identity Management and Authentication Services to Global Payout's MoneyTracTM Consolidated Payment Gateway

Global Payout Announces Significant Increase In Revenue for Third Quarter 2013; New CEO Interview Now Available

Global Payout's MoneyTrac™ Prepaid Discover® Card Can Now be Loaded at 60,000 Green Dot® Retail Locations

Nexus Enterprise Solutions, Inc. (NXES)

The QualityStocks Daily Newsletter would like to spotlight Nexus Enterprise Solutions, Inc. (NXES). Today, Nexus Enterprise Solutions, Inc. closed trading at $0.34, up 36.00%, on 600 volume with 1 trade. The stock’s average daily volume over the past 60 days is 7,545, and its 52-week low/high is $0.25/$0.34.

Nexus Enterprise Solutions, Inc. (NXES) focuses on the auto, health, and life insurance lead generation business. The company markets its services to agencies, agent networks, and insurance carriers throughout the United States. Lead campaigns are fully customizable based on the need of the buyer whether it’s geo-targeting, specific age demographics, or whatever the carrier or agency requires.

The company leverages a suite of proprietary processes and systems designed to identify customers that are more likely to grow with its clients beyond a single transaction. Nexus Enterprise is a recognized leader in providing a broad range of internet marketing strategies to capture targeted buyer data and use that data to generate revenues through both affiliate marketing and lead generation sales.

By working with multiple carriers and agencies, Nexus Enterprise ensures lead coverage throughout the United States. The company provides real-time reporting and its payment schedule can be structured either on a weekly or monthly schedule. Additionally, all traffic is hosted and run on its own landing pages and websites, which the company has done extensive A/B and multivariate testing to ensure optimization for peak performance.

The team of individuals behind Nexus Enterprise has a tremendous amount of experience and success in lead generation. Holding fast to the belief that top quality leads are necessary for a top quality company, the company’s staff implements its in-house expertise with PPC, SEO, social networking, and e-mail traffic to generate the best real-time leads for Nexus Enterprise’s growing list of clients. Disclaimer

Nexus Enterprise Solutions, Inc. Company Blog

Nexus Enterprise Solutions, Inc. News:

Nexus Enterprise Solutions, Inc. Expansion Continues With Push Into Life Insurance Lead Generation

Nexus Enterprise Solutions, Inc. Catapults into Profitability

Nexus Enterprise Solutions, Inc. Announces Support for Federal Communications Commission Issuance of TCPA Regulations

OxySure Systems, Inc. (OXYS)

The QualityStocks Daily Newsletter would like to spotlight OxySure® Systems, Inc. (OXYS). Today, OxySure Systems, Inc. closed trading at $0.75, up 0.67%, on 12,447 volume with 10 trades. The stock’s average daily volume over the past 60 days is 7,486, and its 52-week low/high is $0.35/$2.75.

OxySure Systems, Inc. (OXYS) is a medical technology company focused on developing, manufacturing, and distributing specialty respiratory and medical solutions. The company has developed a unique platform technology that instantly creates medically pure oxygen from two dry, inert powders, allowing oxygen to be delivered on demand. This cutting-edge technology has already been granted FDA-approved for commercial sale.

The company is targeting multiple enormous end markets with no direct competition. OxySure initially plans to focus on the 102,265 educational campuses, 350,735 manufacturing facilities, 350,000 churches, 12 million recreational vehicles (RVs), 8 million boats and yachts, 950,000 restaurants, and hundreds of thousands of other commercial and municipality facilities in the U.S. Outside the US, OxySure has also already signed significant distribution agreements, including Australia, New Zeeland, the United Kingdom, the Netherlands, Luxembourg, Belgium, Brazil, and South Africa. OxySure’s potential market is at least as large as AEDs and potentially as large as fire extinguishers, which together total at least 500+ million units worldwide.

OxySure’s flagship product, OxySure Model 615, introduces the first new oxygen technology in 50 years. There are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the technology is both safe and easy-to-use for the layperson. It can be placed virtually anywhere to help save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.

The company aims to capitalize on market opportunities primarily through partnerships with distributors and OEM customers. Protected by numerous issued patents and patents pending, the company’s products are available over-the-counter without the need for a prescription and has already saved thousands of lives around the globe during various types of medical emergencies. Disclaimer

OxySure Systems, Inc. Company Blog

OxySure Systems, Inc. News:

OxySure Hires Former Paramedic/Firefighter as Director of Safety Development

OxySure Systems: Undervalued, High Growth Potential

OxySure Systems, Inc. Launches OxySure Commercial Finance

Ecrypt Technologies, Inc. (ECRY)

The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.151, up 0.67%, on 11,453 volume with 2 trades. The stock’s average daily volume over the past 60 days is 9,194 and its 52-week low/high is $0.055/$0.28.

Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.

Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.

The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.

Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer

Ecrypt Technologies, Inc. Blog

Ecrypt Technologies, Inc. News:

Ecrypt Technologies, Inc. CEO Featured in Exclusive QualityStocks Interview

Ecrypt Focuses on Immediately Addressable Market

Ecrypt Technologies Receives Patent Pending Status

Intelimax Media, Inc. (IXMD)

The QualityStocks Daily Newsletter would like to spotlight Intelimax Media, Inc. (IXMD). Today, Intelimax Media, Inc. closed trading at $0.035, even for the day, on 110,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 90,579, and its 52-week low/high is $0.0032/$0.39.

Intelimax Media, Inc. (IXMD) is a digital entertainment company specializing in fantasy sports, social gaming, entertainment, and software solutions. Primarily focused on the daily fantasy sports and social gaming sectors, the company is applying its advanced technologies to fully capitalize on the convergence of key trends in the ever-expanding social gaming space.

The company’s team of experts has identified key opportunities in the rapidly emerging daily fantasy sports and social media sectors. Leveraging its proprietary DraftTeam.com platform, the company is generating multiple revenue streams. Innovative plans for international expansion are underway to maximize exposure and traffic through various online and mobile channels.

It's estimated by the Fantasy Sports Trade Association that over 40 million people play some form of a fantasy sport each year in North America. Participation has grown over 30 percent annually the past four years with 19 percent of all males in the U.S. playing fantasy sports. Fantasy sports are estimated to have a $4–$5 billion annual economic impact across the sports industry.

Intelimax Media offers exciting and entertaining online brands that attract a loyal audience and in turn facilitate lucrative revenues from management fees, product placement, and software sales. Backed by personnel with a proven track record in the finance, growth and development of successful companies, the company is poised for rapid growth in the Internet and entertainment sectors.

Intelimax Media also trades on the Canadian market under the symbol (IMD). Disclaimer

Intelimax Media, Inc. Company Blog

Intelimax Media, Inc. News:

Intelimax launches 2013/14 NHL Hockey on DraftTeam.com

Intelimax Launches New Daily Fantasy Sports Platform on DraftTeam.com

Intelimax - Corporate Update

Boston Therapeutics, Inc. (BTHE)

The QualityStocks Daily Newsletter would like to spotlight Boston Therapeutics, Inc. (BTHE). Today, Boston Therapeutics, Inc. closed trading at $1.30, even with yesterday's close, on 14,649 volume with 10 trades. The stock’s average daily volume over the past 60 days is 15,139, and its 52-week low/high is $0.15/$1.65.

Boston Therapeutics, Inc. (BTHE) is a pharmaceutical company focused on the development and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs. An IP portfolio solidifies the company's position in the pharmaceutical industry. Boston Therapeutics' current product pipeline, PAZ320 and IPOXYNT, is comprised of therapies developed to treat patient populations with Type 2 diabetes.

PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes that release glucose from complex carbohydrate in foods during digestion. Boston Therapeutics believes PAZ320 is a safe and effective drug compound for people with pre-diabetes and diabetes in their daily management of blood glucose levels, fulfilling an unmet medical need. PAZ320 has completed a Phase ll clinical trial at Dartmouth Medical Center. 45% of the patients responded with a 40% reduction in the elevation of post meal blood sugar compared to baseline with no serious adverse events.

IPOXYNT, a universal oxygen carrier, is an injectable Rx for prevention of necrosis and treatment of ischemic conditions which may lead to necrosis. This compound is not a biologic, but a second generation New Chemical Entity HBOC (hemoglobin based oxygen carrier). The potential for this product goes well beyond Lower Limb Ischemia into a range of areas from anemia and blood loss (injury), to cardiovascular disease and surgical blood supplementation.

The Boston Therapeutics management and advisory team has extensive expertise in complex carbohydrate chemistry, regulatory affairs, and clinical development, with multiple submissions and approvals to U.S. Food and Drug Administration. Backed by a team with more than five decades of expertise in public and private business management, the company is well positioned to advance its status as a premier developer of complex carbohydrate-based new chemical entities. Disclaimer

Boston Therapeutics, Inc. Company Blog

Boston Therapeutics, Inc. News:

Boston Therapeutics to Present at the Livingston Securities Advanced and Nano Life Sciences Summit

Boston Therapeutics Initiates Research Study on PAZ320 at University of Minnesota

Boston Therapeutics Closes $5.3 Million in Private Placement of Common Stock and Warrants


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Real Pennies


Pumps and Dumps

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251